| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
686,652
|
693,122
|
1,109,475
|
878,576
| | Cost of Revenue | 453,929 | 448,005 | 523,623 | 480,959 | | |
Gross Profit
|
232,723
|
245,117
|
585,852
|
397,617
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 42,070 | 40,560 | 37,529 | 42,522 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 103,730 | 103,268 | 100,353 | 100,606 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
86,923
|
101,289
|
447,970
|
254,489
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 7,860 | 4,180 | 4,262 | 6,130 |
|
Earnings Before Interest And Taxes | 94,783 | 105,469 | 452,232 | 260,619 |
|
Interest Expense | 49,478 | 52,407 | 52,242 | 53,000 |
|
Income Before Tax | 45,305 | 53,062 | 399,990 | 207,619 |
|
Income Tax Expense | 12,469 | 18,157 | 147,116 | 76,689 |
|
Minority Interest | (8,392) | (8,040) | (8,040) | (7,766) |
|
|
|
Net Income From Continuing Ops | 32,836 | 34,905 | 252,874 | 130,930 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
| (4,234) | (11) | (819) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
32,836
|
30,671
|
268,405
|
114,569
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
24,444
|
22,631
|
244,823
|
122,345
|
|
0.21(0.35%) 3:07PM EDT - Nasdaq Real Time Price